P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY

P1292: BASILIXIMAB MAY BE THE POTENTIAL SOLUTION FOR SEVERE LIVER CHRONIC GRAFT-VERSUS-HOST DISEASE: A PROSPECTIVE PILOT STUDY

Bibliographic Details
Main Authors:	Dao-Xing Deng, Meng-Zhu Shen, Xiao-Hui Zhang, Lanping Xu, Yu Wang, Chen-Hua Yan, Yu-Hong Chen, Huan Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Xiao-Jun Huang, Xiao-Dong Mo
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000972056.91461.24

Similar Items

Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment
by: Cong Cheng, et al.
Published: (2024-03-01)

Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment
by: Dao-Xing Deng, et al.
Published: (2022-07-01)

Basiliximab Treatment for Patients With Steroid-Refractory Acute Graft-Versus-Host Disease Following Matched Sibling Donor Hematopoietic Stem Cell Transplantation
by: Xin-Ya Jiang, et al.
Published: (2024-06-01)

Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial
by: Haixia Fu, et al.
Published: (2024-02-01)

Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease
by: Zicheng Gao, et al.
Published: (2024-07-01)

Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study
by: Yamin Tan, et al.
Published: (2017-03-01)

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial
by: Ke Zhao, et al.
Published: (2022-03-01)

Corneal perforation associated with ocular graft-versus-host disease
by: Yue Xu, et al.
Published: (2022-09-01)

Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease
by: XiaoYan Yue, et al.
Published: (2024-02-01)

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-05-01)

The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
by: Meng-Ge Gao, et al.
Published: (2021-09-01)

Fatal anaphylactic reaction due to Basiliximab
by: Patricia Lovisolo, et al.
Published: (2017-04-01)

Optimizing use of basiliximab in liver transplantation
by: Carlo B Ramirez, et al.
Published: (2010-01-01)

From support to therapy: rethinking the role of nutrition in acute graft-versus-host disease
by: Rachel Limpert, et al.
Published: (2023-06-01)

Caspase-11 signaling enhances graft-versus-host disease
by: Yanyan Lu, et al.
Published: (2019-09-01)

Nourrir et loger la cour de Sanche IV (1292-1294)
by: Sophie Coussemacker
Published: (2010-05-01)

Reply to: “correspondence about “Efficacy and safety of basiliximab”
by: Mohamed Hashim, et al.
Published: (2022-03-01)

Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
by: Yue Hu, et al.
Published: (2017-03-01)

Meta-Analysis of Interleukin-2 Receptor Antagonists as the Treatment for Steroid-Refractory Acute Graft-Versus-Host Disease
by: Meng-Zhu Shen, et al.
Published: (2021-09-01)

Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant
by: Chen-Hua Yan, et al.
Published: (2016-09-01)

Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis
by: Shuang Fan, et al.
Published: (2022-08-01)

Basiliximab for the therapy of acute T cell–mediated rejection in kidney transplant recipient with BK virus infection: A case report
by: Tingting Chen, et al.
Published: (2022-09-01)

Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant
by: Chen-Hua Yan, et al.
Published: (2019-03-01)

γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation
by: Ning Wu, et al.
Published: (2021-07-01)

Low-dose rabbit anti-thymoglobin globulin versus basiliximab for induction therapy in kidney transplantation
by: Himanshu V Patel, et al.
Published: (2014-01-01)

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
by: Plata-Munoz, J, et al.
Published: (2009)

Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft--host disease after haploidentical allogeneic hematopoietic stem cell transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-01-01)

The role of basiliximab in renal function after liver transplantation
by: Mikel Gastaca, MD
Published: (2022-03-01)

Author Correction: Caspase-11 signaling enhances graft-versus-host disease
by: Yanyan Lu, et al.
Published: (2020-03-01)

P1317: TIME-DEPENDENT ANALYSIS OF THE IMPACT ON EARLY CMV REACTIVATION OF HLA MISMATCH AND ACUTE GRAFT-VERSUS-HOST-DISEASE AFTER ALLO-HSCT FROM RELATED DONORS IN ACQUIRED APLASTIC ANEMIA.
by: Fan Lin, et al.
Published: (2023-08-01)

Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
by: Ying-Jun Chang, et al.
Published: (2018-12-01)

Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation
by: Jacobo López-Abente, et al.
Published: (2021-01-01)

T cell metabolism in graft-versus-host disease
by: Yujing Zou, et al.
Published: (2020-01-01)

Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
by: Dong Wang, et al.
Published: (2021-06-01)

Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?
by: Xiao-Su Zhao, et al.
Published: (2019-08-01)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
by: Haynes, R, et al.
Published: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
by: Haynes, R, et al.
Published: (2014)

The Approach of Akhtar Newspaper (1292-1314) towards the Religion Based on the Idea of Islamic Unity (Pan Islamism)
by: darush gholami, et al.
Published: (2022-05-01)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
by: Ricardo Wang, et al.
Published: (2015-01-01)

Clinical-economic impact of the change of protocol for use of basiliximab in liver transplant
by: Enrique Tévar-Alfonso, et al.
Published: (2019-01-01)